Literature DB >> 2406801

Epidemiology and natural history of systemic sclerosis.

V D Steen1, T A Medsger.   

Abstract

Systemic sclerosis is an acquired generalized disorder of connective tissue characterized epidemiologically by several distinctive features. From a demographic viewpoint, the disease spares children and its incidence increases steadily with age among adults; is much more frequent in women, especially during the childbearing years; occurs most frequently and severely in young black women, but overall has no prominent racial predilection. If any conclusions can be drawn here, the strongest influences may be age-related hormonal factor and degenerative vascular processes. Family and genetic studies suggest a weak genetic predisposition. There are many environmental agents which may be implicated in pathogenesis. The result of host factors and environmental "triggers" is a multi-system disease which has as prominent features microvascular injury, immunologic dysregulation, and fibroblast activation. The resulting widespread pathologic process leads to vascular insufficiency and fibrosis, which diminishes the reserve function of many organ systems. The result, a significant reduction in lifespan, with a 10-year survival from diagnosis of under 50 per cent. Further epidemiologic studies should take full advantage of established and newly proposed subsets of patients with homogeneous clinical, laboratory, serologic, and natural history features. The environment-host interactions noted above must be fully explored, especially in early untreated disease, where primary rather than secondary mechanisms are most likely to be operative.

Entities:  

Mesh:

Year:  1990        PMID: 2406801

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  29 in total

Review 1.  Bone marrow transplantation in the treatment of systemic sclerosis.

Authors:  F Viganego; R Nash; D E Furst
Journal:  Curr Rheumatol Rep       Date:  2000-12       Impact factor: 4.592

2.  Renal disease in systemic sclerosis with normal serum creatinine.

Authors:  Reem H A Mohamed; Hania S Zayed; Amr Amin
Journal:  Clin Rheumatol       Date:  2010-02-23       Impact factor: 2.980

3.  Increased sensitivity to extracellular ATP of fibroblasts from patients affected by systemic sclerosis.

Authors:  Andrea Lo Monaco; Sara Gulinelli; Gabriella Castellino; Anna Solini; Davide Ferrari; Renato La Corte; Francesco Trotta; Francesco Di Virgilio
Journal:  Ann Rheum Dis       Date:  2007-08       Impact factor: 19.103

Review 4.  Recent advances in the treatment of systemic sclerosis.

Authors:  Vasiliki Kalliopi K Bournia; Panayiotis G Vlachoyiannopoulos; Carlo Selmi; Haralampos M Moutsopoulos; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

5.  Late-age onset systemic sclerosis.

Authors:  Rebecca L Manno; Fredrick M Wigley; Allan C Gelber; Laura K Hummers
Journal:  J Rheumatol       Date:  2011-06-17       Impact factor: 4.666

6.  Exon-1 polymorphism of ctla-4 gene is not associated with systemic sclerosis in Iranian patients.

Authors:  A Rajaee; A Ebrahimi; A Fotouhi Ghiam; T Kalantari; A Ghaderi
Journal:  Rheumatol Int       Date:  2005-09-28       Impact factor: 2.631

7.  Increased transendothelial migration of scleroderma lymphocytes.

Authors:  G H Stummvoll; M Aringer; J Grisar; C W Steiner; J S Smolen; R Knobler; W B Graninger
Journal:  Ann Rheum Dis       Date:  2004-05       Impact factor: 19.103

8.  Scleroderma renal crisis as a possible complication of cyclosporin A withdrawal.

Authors:  P Casoli; C Carretti; B Tumiati
Journal:  Clin Rheumatol       Date:  1994-03       Impact factor: 2.980

9.  Antinuclear antibodies and breast implants.

Authors:  H N Claman; A D Robertson
Journal:  West J Med       Date:  1994-03

10.  Circulating androgens in male patients suffering from systemic scleroderma.

Authors:  G B Jemec; J H Sindrup
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.